Replies to post #8109 on GTC Biotherapeutics (fka GTCB)

[jessellivermore]

Dear OKY....I agree with you 100%

Who on this board really knows what was going on with partnership agreements. My guess is the "partner eventually held out either for a share of the US HD Atryn sales profits or was unwilling to provide sufficient up front money for the DIC trials. Splitting the HD profits, might prvide the company with some walking around money now, but would create long term problems. GTCB would be right to say no to those deals.

The financials market has been bad for some time now...see Sub Prime loans to bail out real estate. Who knows how much sucess GTCB would have had going to the bankers without the P3 TLD and without a partnership agreement. A real "Catch 22 the partners, waiting for the P3 data and realizing GTCB was in a cash crisis and putting the squeeze on them. Maybe it was not just management incompetence,,,

So Cox made 650,000$ in salary,, for you chuckleheads out there who think he does not care about the PPS consider the fact he controls over a million shares of GTCB including options etc. when the PPS fell thirty cents after the dilution his paper loses were over 300,000$ a very percetage of his yearly salary,,,,think he liked that

[doofus_king]

Cox shouldn't have provided guidance for cash that wasn't a done deal. He should have gotten a deal done. Instead he looks like he flubbed it and has to raise cash from a precarious position. To those who say the dilution might be a good deal in the long run, do you realize that the 15% dilution is forever. It doesn't matter if they go bankrupt but it does matter if you think gtcb will be a robust profit making machine. 15% of all future profits were just traded for $6 million. fire the ceo or the cfo. or both. the buck stops where?